Insider · CIK 0001983513
Colin McHugh
Files at ACCD (Accolade, Inc.). First filing Nov 3, 2023, latest Jan 6, 2025.
In brief
Colin McHugh files SEC Form 4 as officer at ACCD (Accolade, Inc.). Since Nov 3, 2023, Colin McHugh has reported 0 open-market buys worth $0 and 5 open-market sells worth $17k, the latest filed on Jan 6, 2025.
A track record needs three past buys with six months of prices behind them; Colin McHugh has 0, so none is measured yet.
The newest scored trade: sold $1,785 of ACCD on Jan 3, 2025, filed Jan 6, 2025, scored 15 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Accolade, Inc. | $1,785 524 shares | -1% | - | |
| 15Weak | Accolade, Inc. | $8,585 2,388 shares | -4% | - | |
| 15Weak | Accolade, Inc. | $1,411 448 shares | -1% | - | |
| 15Weak | Accolade, Inc. | $3,202 353 shares | -1% | - | |
| 15Weak | Accolade, Inc. | $2,374 345 shares | -1% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 2, 2025 | ACCD Accolade, Inc. | 504 0.00% of outstanding | $3,524 | Apr 2, 2025 | $8,798 |
| Mar 4, 2025 | ACCD Accolade, Inc. | 504 0.00% of outstanding | $3,508 | Mar 4, 2025 | $5,290 |
| Feb 4, 2025 | ACCD Accolade, Inc. | 506 0.00% of outstanding | $3,504 | Feb 4, 2025 | $12k |
| Jan 3, 2025 | ACCD Accolade, Inc. | 524 0.00% of outstanding | $1,785 | Jan 3, 2025 | $9,996 |
| Dec 3, 2024 | ACCD Accolade, Inc. | 2,388 0.00% of outstanding | $8,585 | Dec 3, 2024 | $4,887 |
| Nov 4, 2024 | ACCD Accolade, Inc. | 448 0.00% of outstanding | $1,411 | Nov 4, 2024 | $3,476 |
| Dec 4, 2023 | ACCD Accolade, Inc. | 353 0.00% of outstanding | $3,202 | Dec 4, 2023 | $11k |
| Nov 2, 2023 | ACCD Accolade, Inc. | 345 0.00% of outstanding | $2,374 | Nov 2, 2023 | $14k |
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | ACCD Accolade, Inc. | MOption exercise Common Stock | +145 | $0.00 | $0 | 61,201 | Jan 6, 2025 |
| Jan 2, 2025 | ACCD Accolade, Inc. | MOption exercise Common Stock | +1,389 | $0.00 | $0 | 62,590 | Jan 6, 2025 |
| Jan 3, 2025 | ACCD Accolade, Inc. | SOpen-market sale Common Stock | -524 | $3.41 | $1,785 | 62,066 | Jan 6, 2025 |
| Jan 2, 2025 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -145 | - | - | 726 | Jan 6, 2025 |
| Jan 2, 2025 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,389 | - | - | 23,612 | Jan 6, 2025 |
| Dec 2, 2024 | ACCD Accolade, Inc. | MOption exercise Common Stock | +145 | $0.00 | $0 | 55,673 | Dec 4, 2024 |
| Dec 2, 2024 | ACCD Accolade, Inc. | MOption exercise Common Stock | +1,389 | $0.00 | $0 | 57,062 | Dec 4, 2024 |
| Dec 2, 2024 | ACCD Accolade, Inc. | MOption exercise Common Stock | +6,382 | $0.00 | $0 | 63,444 | Dec 4, 2024 |
| Dec 3, 2024 | ACCD Accolade, Inc. | SOpen-market sale Common Stock | -2,388 | $3.60 | $8,585 | 61,056 | Dec 4, 2024 |
| Dec 2, 2024 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -145 | - | - | 871 | Dec 4, 2024 |
| Dec 2, 2024 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,389 | - | - | 25,001 | Dec 4, 2024 |
| Dec 2, 2024 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,382 | - | - | 0 | Dec 4, 2024 |
| Nov 1, 2024 | ACCD Accolade, Inc. | MOption exercise Common Stock | +146 | - | - | 54,587 | Nov 5, 2024 |
| Nov 1, 2024 | ACCD Accolade, Inc. | MOption exercise Common Stock | +1,389 | - | - | 55,976 | Nov 5, 2024 |
| Nov 4, 2024 | ACCD Accolade, Inc. | SOpen-market sale Common Stock | -448 | $3.15 | $1,411 | 55,528 | Nov 5, 2024 |
| Nov 1, 2024 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -146 | - | - | 1,016 | Nov 5, 2024 |
| Nov 1, 2024 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,389 | - | - | 26,390 | Nov 5, 2024 |
| Dec 1, 2023 | ACCD Accolade, Inc. | MOption exercise Common Stock | +145 | - | - | 33,097 | Dec 5, 2023 |
| Dec 1, 2023 | ACCD Accolade, Inc. | MOption exercise Common Stock | +1,087 | - | - | 34,184 | Dec 5, 2023 |
| Dec 4, 2023 | ACCD Accolade, Inc. | SOpen-market sale Common Stock | -353 | $9.07 | $3,202 | 33,831 | Dec 5, 2023 |
| Dec 1, 2023 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -145 | - | - | 2,613 | Dec 5, 2023 |
| Dec 1, 2023 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,087 | - | - | 6,522 | Dec 5, 2023 |
| Nov 1, 2023 | ACCD Accolade, Inc. | MOption exercise Common Stock | +145 | - | - | 32,210 | Nov 3, 2023 |
| Nov 1, 2023 | ACCD Accolade, Inc. | MOption exercise Common Stock | +1,087 | - | - | 33,297 | Nov 3, 2023 |
| Nov 2, 2023 | ACCD Accolade, Inc. | SOpen-market sale Common Stock | -345 | $6.88 | $2,374 | 32,952 | Nov 3, 2023 |
| Nov 1, 2023 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -145 | - | - | 2,758 | Nov 3, 2023 |
| Nov 1, 2023 | ACCD Accolade, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,087 | - | - | 7,609 | Nov 3, 2023 |
Questions about Colin McHugh
Answered from the filings on this page, as of the latest one.
Is Colin McHugh buying or selling?
Not in the last 12 months. Colin McHugh's latest open-market trade on SEC Form 4 was sold $1,785 of ACCD on Jan 3, 2025.
How did Colin McHugh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Colin McHugh has 0.
Where does Colin McHugh file Form 4?
Colin McHugh has filed Form 4 at ACCD (Accolade, Inc.) as Chief Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.